Ambisome and Infusion site rash - a phase IV clinical study of FDA data

Summary:

Infusion site rash is reported only by a few people who take Ambisome.

The phase IV clinical study analyzes which people take Ambisome and have Infusion site rash. It is created by eHealthMe based on reports of 7,381 people who have side effects while taking Ambisome from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 03, 2022

7,381 people reported to have side effects when taking Ambisome.
Among them, 2 people (0.03%) have Infusion site rash.


What is Ambisome?

Ambisome has active ingredients of amphotericin b. eHealthMe is studying from 7,387 Ambisome users for its effectiveness, alternative drugs and more.

What is Infusion site rash?

Infusion site rash is found to be associated with 348 drugs and 137 conditions by eHealthMe.

Number of Ambisome and Infusion site rash reports submitted per year:

Could Ambisome cause Infusion site rash?

Gender of people who have Infusion site rash when taking Ambisome *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Infusion site rash when taking Ambisome *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 100 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Ambisome *:

  1. Cancidas: 2 people, 100.00%

Common side effects people have besides Infusion site rash *:

  1. Catheter Site Inflammation (infection at catheter site): 1 person, 50.00%
  2. Catheter Site Erythema (redness of skin at catheter site): 1 person, 50.00%

Common conditions people have *:

  1. Fungal Infection: 2 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ambisome and have Infusion site rash?

Check whether Infusion site rash is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Infusion site rash and when was it recovered:

Expand to all the drugs that have ingredients of amphotericin b:

Alternative drugs to, pros and cons of Ambisome:

Common Ambisome side effects:

Browse all side effects of Ambisome:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Infusion site rash treatments and more:

COVID vaccines that are related to Infusion site rash:

Common drugs associated with Infusion site rash:

All the drugs that are associated with Infusion site rash:

Common conditions associated with Infusion site rash:

All the conditions that are associated with Infusion site rash:

How the study uses the data?

The study uses data from the FDA. It is based on amphotericin b (the active ingredients of Ambisome) and Ambisome (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: